Regulators are expected to make a decision in the third quarter of 2025 on Kerendia to treat patients with heart failure with ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

At a Senate confirmation hearing for CMS administrator, Mehmet Oz, M.D., would not answer directly whether he would support ...

When disasters occur, organizations such as SCAN Health Plan take a holistic approach, considering the needs of members, ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Patients with acute kidney injury requiring temporary hemodialysis often follow the protocol used for people on long-term ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

The new bill would also require state Medicaid programs to report National Average Drug Acquisition Costs (NADAC) as a way to ...

In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...

Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps ...

Celltrion’s Omlyclo is interchangeable with Xolair to treat the same conditions: asthma, chronic rhinosinusitis, food allergy ...

Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.